Cardiovascular Biomaterials Special Interest Group aims to bring together researchers from academia, industry, and the clinic with a common interest related to cardiovascular applications. The objectives of this SIG are to:
- suggest, organize, and implement symposia, workshops, tutorials, and general scientific sessions at the SFB Annual Meeting and other SFB-sponsored meetings
- provide networking opportunities for researchers in cardiovascular applications to foster new collaboration
- enhance education in the area of cardiovascular biomaterials and bioengineering, by contributing articles to relevant publications and organizing educational sessions at meetings
- collaborate with other SIGs to further the goals of the Society as a whole, and to promote advances in biomedical materials research in a broad range of applications
Following is a list of the Cardiovascular related sessions that will be held at the SFB 2023 Annual Meeting:
Biomaterials for Cardiovascular Regeneration
This session includes research on biomaterials-based engineering for cardiovascular regeneration, including the role of extracellular matrix (ECM) and stem cells in cardiovascular tissue development; whole-heart engineering with spatially controlled and temporal growth factors that regulate cardiovascular tissue regeneration and vascularization. Strategies for design of 3D scaffolds to engineer myocardium, vessels, and organoids with appropriate biochemical and mechanical characteristics are also covered.
This session will highlight recent advances in both in vitro and in vivo strategies employed for engineering 3D scaffolds to regenerate cardiovascular tissues with appropriate biochemical and mechanical characteristics for modulating cellular behavior and activation of highly regulated signaling pathways. We also invite research abstracts on research advances in ECM component-incorporated biomaterials, engineering of complex 3D structures using biofabrication and spatial patterning techniques, as well as translation of engineered scaffolds for cardiovascular regenerative medicine.
Cardiovascular Biomaterials (SIG)
The Cardiovascular Special Interest Group has the mission to foster the professional interaction and address the common concerns of academic and industrial scientists and engineers, clinicians, and regulatory professionals concerned with the discovery, research, development, and use of biomaterials for cardiovascular devices and implants.
Biomanufacturing is an emerging field for developing technologies to fabricate bio-related products using natural or synthetic or hybrid biomaterials, and cells and cell-based products. This session will highlight the development and application of 3D-printed cardiovascular products, organoids, organ-on-chips, vascularized constructs, and other related products for cardiovascular engineering.
Drug Delivery for Cardiovascular Applications
Drug delivery is currently an important part of cardiovascular biomaterials including drug-eluting stents, vascular grafts, cardiac patches, and angiogenesis strategies. However, there are still new biomaterials and controlled release strategies that are needed. Topics of interest include methods to prevent thrombosis, intimal hyperplasia, scar tissue formation, and infection of cardiovascular grafts.
New Materials and Approaches to Enhance Current Cardiovascular Devices
While there are cardiovascular grafts commonly used clinically, there is a need for innovative biomaterials and approaches to improve these types of devices. For example, new regulations on fluoropolymers may impact the manufacture of ePTFE grafts. This session is interested in abstracts from researchers with innovative ideas relevant for different types of cardiovascular devices but also with a consideration of the potential for translation. This is also a chance to engage industry with the new research strategies being developed in the field.